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Abstract: Purpose: The aim of this study
was to determine the risk factors in the
development of total parenteral nutrition
associated cholestasis which is a significant
clinical problem for pediatric surgeons.
Methods: The medical records of 54
neonates who had received total parenteral
nutrition for more than two weeks were
reviewed retros pectively. Prematurity,
duration of parenteral nutrition, enteral
starvation, composition of the parenteral
nutrition solution, the number of septic
episodes and the presence of jejunostomy
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were evaluated as risk factors. The results
were analyzed by dividing the patients into
two groups, based on conjugated plasma

bilirubin levels (greater or less than 2 mg/dl)
during total parenteral nutrition.
Results: There were significant differences
between the two groups with respect to birth
weight, gestational age at birth, duration of
enteral starvation, the number of septic
episodes and the presence of jejunostomy.
Conclusion:
The
interruption
of
enterohepatic circulation (by enteral
starvation, IV administration of nutrients and
the presence of jejunostomy) is one of the
most important factors in the development of
total parenteral nutrition -associated
cholestasis.
Key Words: Total parenteral nutrition,
cholestasis, enterohepatic circulation.

Introduction

Materials and Methods

The major complication of total parenteral nutrition
(TPN) in neonates is cholestatic jaundice leading to liver
failure. Although enteral feeding in otherwise healthy
neonates has almost eliminated total parenteral nutritionassociated cholestasis (TPNAC), it remains a significant
clinical problem for the pediatric surgeon who treats
neonates with diseases of the gastrointestinal tracts that
require prolonged parenteral nutrition. Its pathogenesis
is not well known. Abdominal surgery, enteral starvation,
number of operations, prematurity, recurrent septicemia
from the central venous catheter, and intestinal bacterial
overgrowth, duration of parenteral nutrition and
composition of TPN solution have been identified as
potential factors in the development of TPNAC (1-6).

Fifty-four neonates who had received TPN for more
than two weeks were included in the study. They were
followed up until the TPN was discontinued or until
death. The medical records of the 54 neonates were
reviewed, and the following data were extracted: birth
weight, gestational age at birth, age at beginning of TPN,
total duration of TPN, the composition of TPN solutions,
duration of enteral starvation, number of septic episodes
(defined as positive blood culture in association with one
or more of the following symptoms: fever, hypothermia,
hypotonia, hypotension, trombocytopenia, elevated
neutrophil count), plasma bilirubin levels and the presence
of jejunostomy.

The aim of this study was to determine the risk
factors, including the presence of jejunostomy which
interrupts enterohepatic circulation of bile acids.

The diagnoses were gastroschisis (10), necrotizing
enterocolitis (9), intestinal atresia (11), meconium ileus
(6), malrotation with midgut volvulus (7), bacterial sepsis
(3), and others.
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The results were analyzed by dividing the patients into
two groups, based on conjugated plasma bilirubin level
(greater or less than 2 mg/dl) during TPN. The
parameters were compared in each group, using the
Mann-Whitney U test or the Yates’ corrected chi square
test where appropriate.
Since some parameters are linked, the multiple logistic
regression test was used to relate TPNAC to possible
associated factors.
Results
Cholestatic jaundice had developed in 16 subjects
(29.6%). Two subjects who had jejunostomy died of liver
failure. Three subjects died of other causes. Eleven
subjects were weaned from TPN, and cholestasis resolved
after cessation of TPN within three months. The results
of the comparison of the two groups are summarized in
table 1. Birth weight, gestational age at birth, the
duration of TPN, duration of enteral starvation, the
number of septic episodes, and the presence of
jejunostomy differed significantly between the two
groups, while there were no significant differences in the
interval between birth and beginning of TPN and the
composition of TPN solution.
Multiple regression analysis indicated that the best

Parameter

predicting factors for TPNAC were the presence of
jejunostomy (p<0.001), gestational age at birth
(p<0.05), the number of septic episodes (p<0.05) and
total duration of enteral starvation (p<0.05). Interval
between birth and beginning of TPN, total duration of
TPN and the composition of TPN solution were found to
be unimportant predicting factors for TPNAC.
Discussion
Moss et al. (6) demonstrated that biochemical indices
of liver function do not necessarily correlate with liver
histology. However, our diagnostic criterion for TPNAC is
elevation of plasma conjugated bilirubin levels, because
of the impossibility of doing the liver biopsy in all
neonates who receive TPN.
One of the factors in the development of cholestasis is
prematurity. This result is in agreement with previous
studies (2, 5), and supports the hypothesis that TPNAC is
primarily attributable to immaturity of the neonatal
hapatobiliary system (7, 8). Unfortunately, most surgical
neonates dependent on long term TPN had low birth
weight and low gestational age and TPNAC may be
unavoidable.
Several studies have implicated the role of intestinal
bacterial overgrowth and septicemia in the development

Cholestatic (n:16)

Noncholestatic (n:38)

Birth weight (kg)

2.13 (1.2-3.4)

2.41(1.5-2.9)#

Gestational age at birth (wk)

35.9 (28-40)

37.4 (30-40)#

3,6 (2-11)

6.1 (2-17) NS

42.4 (18-96)

24.7 (14-56)#

35 (11-52)

21.7 (8-37)#

a.a. gr/kg/day

2.81 (2-3.5)

2.79 (2-3.5) NS

lipid gr/kg/day

3.6 (3-4)

3.51 (3-4) NS

17.11 (13-21)

15.65 (13-20) NS

No of septic episodes

2.1 (0-7)

0.7 (0-4)#

No of subject with jejunostomy*

6 (37.5%)

0 (0%)#

Time between birth and beginning of TPN(day)
Total duration of TPN (day)
Total duration of enteral starvation (day)
Composition of TPN solution

carbohydrate gr/kg/day

Maximum conjugated bilirubin mg/dl

7.1 (2.3-15.0)

1.1 (0.3-1.9)

Data are expressed as mean value and ranges, statistical analysis was performed the Mann-Whitney U
test and Yates’ corrected chi square test (*), # p<0.05, NS not significant.
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Table 1.

The
comparison
of
cholestatic
and
noncholestatic neonates
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of TPNAC (2, 3, 5, 9). Further supporting this are studies
that have shown a decreased incidence of liver disease
when metranidazole and gentamycine are administered
during TPN (9-12). Bacterial endotoxins (e.g. E. coli
endotoxin), which decrease Na+ - K+ ATPase activity in
the membrane of hepatocytes, may also decrease bile
flow (13).
The most widely accepted hypothesis for the
explanation of TPNAC is that a lack of fat in the
duodenum leads to stasis in the enterohepatic circulation,
which then leads to the histological changes seen in the
liver in this syndrome. Conjugated hyperbilirubinemia
together with elevated serum bile acid levels is part of
TPNAC.
The passage of bile salts into the biliary canaliculus is
the most important factor promoting bile formation.
There is an excellent correlation between bile flow and
bile acid secretion. The bile-acid-dependent pump fails if
inadequate quantities of bile acids reach the canaliculus or
leak from it. Failure of enterohepatic circulation of bile
acid may contribute. It is suggested that ursodeoxycholic
acid is actively absorbed by the ductular cells and
recirculates to the liver for further excretion (13). The
restoration of the bile acid pool by administration of
ursodeoxycholic acid increases the bile acid secretory rate
and bile flow.
The combination of an enteral fast with the IV
administration of all nutrients in a young rabbit resulted
in bile acid sequestration in an adynamic gallbladder with
the interruption of the enterohepatic circulation (14).
Apart from enteral starvation and IV administration of
nutrients, the presence of jejunostomy interrupts the
enterohepatic circulation mostly since the majority of bile
acids are actively absorbed in the terminal ileum (13).

Thus the bile acid pool shrinks progressively and bile flow
is decreased, subsequently enhancing the cholestasis and
liver damage.
Rintala et al. (15) showed that the intractable
cholestasis associated with TPN may be treated by
irrigation of the biliary tree. In experimental and clinical
studies, it has been shown that TPNAC may be reversed
by daily cholecystokinin injections (16-18). Both biliary
tree irrigation and cholecystokinin injection stimulate the
enterohepatic circulation. The presence of normal bile
acids in portal triad from enterohepatic circulation may
suppress the lipocytes either directly or via cytokines such
as transforming growth factor beta. Evidence suggests
that lipocytes are the primary mesanchymal cells
responsible for pathogenic fibrosis (19). The cholestasis
usually resolves when the infant resumes enteral
nutrition (2). In some patients, as in our patients with
jejunostomy, the institution of enteral feeding does not
restore normal bile flow. In these cases, progressive liver
damage, liver failure and death may be inevitable.
The fact that the development of TPNAC in all
neonates who had jejunostomy suggests that one of the
most important factors in the development of TPNAC is
the interruption of enterohepatic circulation. In addition
to the prevention of sepsis, avoidance of jejunal stoma,
institution of enteral feeding as early as possible and
restoration of enterohepatic circulation by various
methods (e.g. irrigation of the biliary tree,
cholecystokinin and ursodeoxycholic acid administration)
may be useful for the prevention of cholestasis in
neonates receiving long term TPN. Furthermore, the
presence of jejunostomy may be a good model for studies
to determine the correlation between TPNAC and
enterohepatic circulation.
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